| The Board of Directors of Biocon Limited at its meeting held on June 17, 2019, considered and approved the sale of Branded Formulations India (BFI) Business of the Company on a 'going concern' basis to Biocon Biologics India Limited ('BBIL'), a wholly owned subsidiary. | | Powered by Capital Market - Live News |
|